T. Rowe Price Associates’s Oscar Health OSCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $56.8M | Buy |
|
|||||
|
2025
Q2 | $14.6M | Sell |
|
|||||
|
2025
Q1 | $43.6M | Sell |
|
|||||
|
2024
Q4 | $63.8M | Sell |
|
|||||
|
2024
Q3 | $114M | Buy |
|
|||||
|
2024
Q2 | $78.4M | Buy |
|
|||||
|
2024
Q1 | $59.2M | Buy |
|
|||||
|
2023
Q4 | $14.4M | Buy |
|
|||||
|
2023
Q3 | $4.81M | Buy |
|
|||||
|
2023
Q2 | $409K | Buy |
|
|||||
|
2023
Q1 | $295K | Buy |
|
|||||
|
2022
Q4 | $107K | Sell |
|
|||||
|
2022
Q3 | $670K | Sell |
|
|||||
|
2022
Q2 | $1.79M | Buy |
|
|||||
|
2022
Q1 | $1.3M | Buy |
|
|||||
|
2021
Q4 | $1.01M | Sell |
|
|||||
|
2021
Q3 | $2.66M | Sell |
|
|||||
|
2021
Q2 | $8.34M | Sell |
|
|||||
|
2021
Q1 | $13.5M | Buy |
|